CD274 and breast cancer: These results support the notion that cotreatment of anti-PD-L1 antibody with radiotherapy greatly suppressed immune escape of tumor cells in miR-21+/+ mice in comparison to anti-PD-L1 antibody treatment or radiotherapy alone, so as to ameliorate radiotherapy resistance of BC cells.